TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/23 17:12 | 4/5/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I | |||||||||||||||
6/28/22 19:48 | 6/24/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | S | -103 | 1.03 | 0 | -99 | -1 | 15,907 | I | |||||||||||||||
6/28/22 19:46 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | P.a | 250 | 1.25 | 0 | 200 | 1 | 16,006 | I | |||||||||||||||
4/29/22 16:33 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | P.ad | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | |||||||||||||||
4/18/22 21:55 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | P.d | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | |||||||||||||||
9/17/21 16:09 | 9/15/21 | SNAX | Stryve Foods, Inc. | FdBev | Food | Food & Kindred Products | Pura Vida Investments, LLC | NY | T | S.d | 0 | 0.00 | 0 | -800 | -64 | 450 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |